Fachrepositorium Lebenswissenschaften

8 Treffer

Suche

Publisso-Menue

Methods and guidance on conducting, reporting, publishing, and appraising living systematic reviews: a scoping review

2023 . Iannizzi, Claire | Akl, Elie A. | Anslinger, Eva | Weibel, Stephanie | Kahale, Lara A. | Aminat, Abina Mosunmola | Piechotta, Vanessa | Skoetz, Nicole

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells

2021 . Braun, Christiane | Schlaweck, Sebastian | Daecke, Solveig Nora | Brossart, Peter | Heine, Annkristin

Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment

2021 . Strobel, Sophia Boyoung | Machiraju, Devayani | Kälber, Katharina A. | Hassel, Jessica C.

CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL

2021 . Reusing, Sarah B. | Vallera, Dan A. | Manser, Angela R. | Vatrin, Titus | Bhatia, Sanil | Felices, Martin | Miller, Jeffrey S. | Uhrberg, Markus | Babor, Florianj

Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma

2021 . Glutsch, Valerie | Kneitz, Hermann | Gesierich, Anja | Goebeler, Matthias | Haferkamp, Sebastian | Becker, Jürgen C. | Ugurel, Selma | Schilling, Bastian

Measuring test-retest reliability (TRR) of AMSTAR provides moderate to perfect agreement – a contribution to the discussion of the importance of TRR in relation to the psychometric properties of assessment tools

2021 . Bühn, Stefanie | Ober, Peggy | Mathes, Tim | Wegewitz, Uta | Jacobs, Anja | Pieper, Dawid

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

2020 . Fietz, Simon | Zarbl, Romina | Niebel, Dennis | Posch, Christian | Brossart, Peter | Gielen, Gerrit H. | Strieth, Sebastian | Pietsch, Torsten | Kristiansen, Glen | Bootz, Friedrich | Landsberg, Jennifer | Dietrich, Dimo

Brief progress report from the intersocietal working group on differentiated thyroid cancer